NCT02453841View on ClinicalTrials.gov

Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 20, 2017

Study Completion Date

April 20, 2017

Conditions
AdenoidectomyFunctional Endoscopic Sinus Surgery (FESS)Turbinate Surgery
Interventions
DRUG

Oxymetazoline

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Richard Cartabuke

OTHER

NCT02453841 - Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption | Biotech Hunter | Biotech Hunter